Published in Pol Merkur Lekarski on April 01, 2005
Elevated TGF-beta1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer. Arch Immunol Ther Exp (Warsz) (2006) 0.99
The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest (2003) 0.95
Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter? Inflammation (2012) 0.91
Acute respiratory failure in a patient with spontaneous esophageal rupture (Boerhaave syndrome). Respir Care (2011) 0.89
[Hemorrhagic parapneumonic effusion in a 64 year-old patient as the first symptom of hemophilia B]. Pneumonol Alergol Pol (2009) 0.88
Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD. Respir Med (2006) 0.86
Comparing supplementary oxygen benefits from a portable oxygen concentrator and a liquid oxygen portable device during a walk test in COPD patients on long-term oxygen therapy. Respir Med (2008) 0.82
Obstructive sleep apnea in shift workers. Sleep Med (2011) 0.82
[The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2006) 0.81
Airway dimensions in asthma and COPD in high resolution computed tomography: can we see the difference? Respir Care (2013) 0.81
[Effects of nurse home visits on compliance to long-term oxygen therapy. 14 months follow-up]. Pneumonol Alergol Pol (2009) 0.81
Diagnosis and management of premature ventricular complexes-associated chronic cough. Chest (2009) 0.80
[Real-time PCR assay for detection and quantification of human adenoviruses in patients with haematological malignancies and symptoms of lower respiratory tract infection]. Przegl Epidemiol (2011) 0.80
[Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer]. Pol Arch Med Wewn (2004) 0.80
The value of cytological diagnosis of small cell lung carcinoma. Pneumonol Alergol Pol (2010) 0.80
Continuous positive airway pressure treatment increases bronchial reactivity in obstructive sleep apnea patients. Respiration (2009) 0.80
Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients. Cytokine (2012) 0.79
[Diagnosis of tuberculous lymphadenitis based on the fine needle aspiration samples analysis]. Pneumonol Alergol Pol (2006) 0.79
[Lymphocyte and lymphocyte subsets in pleural fluid--comparison of malignant and non-malignant disorders]. Pol Arch Med Wewn (2004) 0.79
[Exhaled nitric oxide in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2006) 0.79
[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients]. Pneumonol Alergol Pol (2011) 0.79
[The effect of asthma and COPD exacerbation on exhaled nitric oxide (FE(NO))]. Pneumonol Alergol Pol (2004) 0.78
[The relationship between markers of airway inflammation and thickness of the basement membrane in patients with asthma]. Pneumonol Alergol Pol (2007) 0.78
[Factors influencing asthma course and the degree of control in the patients assessed with own questionnaire and Asthma Control Test (ACT)]. Pneumonol Alergol Pol (2012) 0.78
[Diagnostic utility of the molecular assay GenoType MTBC (HAIN Lifesciences, Germany) for identification of tuberculous mycobacteria]. Pneumonol Alergol Pol (2009) 0.78
[Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS)]. Pneumonol Alergol Pol (2011) 0.78
Effect of exacerbation frequency on body composition and serum ghrelin and adiponectin concentrations in patients with chronic obstructive pulmonary disease. Pol Arch Med Wewn (2014) 0.77
Simplified method of dynamic contrast-enhanced computed tomography in the evaluation of indeterminate pulmonary nodules. Respiration (2009) 0.77
[The influence of gastroesophageal reflux on asthma]. Wiad Lek (2002) 0.77
[Relationship between airway basement membrane thickness and lung function tests in patients with asthma]. Pneumonol Alergol Pol (2009) 0.77
Pleural Effusion in Meigs' Syndrome-Transudate or Exudate?: Systematic Review of the Literature. Medicine (Baltimore) (2015) 0.77
Correlation between hyperinflation defined as an elevated RV/TLC ratio and body composition and cytokine profile in patients with chronic obstructive pulmonary disease. Pneumonol Alergol Pol (2015) 0.77
[Analysis of solitary pulmonary nodules found in chest radiograms]. Pneumonol Alergol Pol (2009) 0.77
[Serum leptin concentration and sympathetic activation estimated on the adrenaline and noradrenaline serum concentration in patients with obstructive sleep apnea]. Pol Arch Med Wewn (2005) 0.76
[Serum concentration of homocysteine and the risk of atherosclerosis in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2006) 0.76
[Role of eotaxin in the pathophysiology of asthma]. Pneumonol Alergol Pol (2007) 0.76
The expression of the eotaxins IL-6 and CXCL8 in human epithelial cells from various levels of the respiratory tract. Cell Mol Biol Lett (2013) 0.76
Prevalence of metabolic syndrome diagnosis in patients with obstructive sleep apnoea syndrome according to adopted definition. Pneumonol Alergol Pol (2013) 0.76
[Usefulness of NT-proBNP serum level in the diagnosis of dyspnea in COPD patients]. Pneumonol Alergol Pol (2013) 0.76
[The role of viruses in the pathogenesis of obstructive lung diseases]. Pol Merkur Lekarski (2003) 0.76
Serum levels of apoptosis-related markers (sFasL, TNF-a, p53 and bcl-2) in COPD patients. Pneumonol Alergol Pol (2015) 0.76
[Sarcoidal reaction in lung adenocarcinoma in 50-years old man]. Pneumonol Alergol Pol (2010) 0.75
[Influence of bronchoscopy on nitric oxide in exhaled air]. Pneumonol Alergol Pol (2006) 0.75
[The role of fiberoptic bronchoscopy in the diagnostic algorithm of solitary pulmonary nodule]. Pneumonol Alergol Pol (2006) 0.75
[Sarcoidosis and tobacco smoking--clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition]. Pol Merkur Lekarski (2012) 0.75
[Mycolic acids analysis from various species mycobacterium by high pressure liquid chromatography (HPLC)]. Pneumonol Alergol Pol (2002) 0.75
[GOLD 2011 - COPD from a new perspective]. Pol Merkur Lekarski (2013) 0.75
Amiodarone induced pneumonitis and hyperthyroidism: case report. Pol Arch Med Wewn (2008) 0.75
Comparison of airway wall remodeling in asthma and COPD: biopsy findings. Respir Care (2011) 0.75
[Pleural fluid interferon-gamma (IFN-gamma) measurement as a diagnostic tool in tuberculous pleurisy]. Pneumonol Alergol Pol (2008) 0.75
The utility of oesophageal pH monitoring in diagnosing gastroesophageal reflux disease-related chronic cough. Pneumonol Alergol Pol (2014) 0.75
[Bronchorrhea in a case of pneumonic type of bronchioloalveolar carcinoma]. Pol Arch Med Wewn (2004) 0.75
[Usefulness of selected tests in the diagnosis of exercise induced bronchoconstriction]. Pneumonol Alergol Pol (2011) 0.75
[Influence of inhaler and fine particle on efficacy of inhalation therapy in COPD]. Pneumonol Alergol Pol (2014) 0.75
[Primary immune thrombocytopenia in a patient with sarcoidosis]. Pneumonol Alergol Pol (2011) 0.75
[Diagnostic utility of pleural fluid eosinophilia]. Pneumonol Alergol Pol (2006) 0.75
[The influence oc glycocorticoid therapy on sputum ECP concentration in symptomatic patients with bronchial asthma]. Pneumonol Alergol Pol (2002) 0.75
[Prevalence of home mechanical ventilation in Poland]. Pneumonol Alergol Pol (2010) 0.75
[Estimation of volume of pleural fluid and its impact on spirometrical parameters]. Pol Merkur Lekarski (2014) 0.75
[Tracheobronchopathia osteochondroplastica]. Pneumonol Alergol Pol (2002) 0.75
[The familial occurrence of obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2007) 0.75
[Modern etio-pathogenesis and diagnosis of mycobacterioses]. Pol Merkur Lekarski (2003) 0.75
[Adenosine deaminase activity in tuberculous and malignant pleural effusions]. Pneumonol Alergol Pol (2006) 0.75
[Lung cancer in COPD--a clinical analysis]. Pol Arch Med Wewn (2002) 0.75
[Mediastinal neuroendocrine tumor (atypical carcinoid probably of thymic origin) imitating teratoma--case report]. Pol Merkur Lekarski (2011) 0.75
[Capsaicin inhalation cough challenge in an evaluation of cough threshold--preliminary study]. Pol Merkur Lekarski (2014) 0.75
[Functional nasal surgery in the treatment of obstructive sleep apnea]. Pneumonol Alergol Pol (2004) 0.75
[Viral infections as exacerbation factor of obstructive pulmonary disease--COPD and asthma. Prevention, diagnostic and therapy problems]. Pol Arch Med Wewn (2003) 0.75
[Megacolon imitating emphysema in the course of diaphragmatic hernia]. Pneumonol Alergol Pol (2004) 0.75
[Clinical consequences of airway remodeling]. Pneumonol Alergol Pol (2004) 0.75
[Combined therapy ICS/LABA--new therapeutical trends in patients with asthma and chronic obstructive pulmonary disease]. Pol Merkur Lekarski (2010) 0.75
[Caplan's syndrome: case report]. Pol Arch Med Wewn (2005) 0.75
[Genetic predisposition to ischemic heart disease in patients with obstructive sleep apnea syndrome (OSAS)]. Pol Merkur Lekarski (2014) 0.75
[Maximal respiratory pressures and exercise tolerance in patients with COPD]. Pneumonol Alergol Pol (2006) 0.75
[Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge]. Pol Arch Med Wewn (2003) 0.75
[10 years survival of patient with lung cancer and cerebral metastasis]. Pneumonol Alergol Pol (2004) 0.75
Heterozygous α1‑antitrypsin deficiency in liver transplant candidates. Pol Arch Med Wewn (2012) 0.75
Leflunomide-induced acute interstitial pneumonia in a patient treated for rheumatoid arthritis. Pneumonol Alergol Pol (2015) 0.75
[Asthma-induced myocardial infarction in a 39-year-old woman]. Pol Merkur Lekarski (2003) 0.75
[Holter ECG monitoring during research bronchofiberoscopy in patients with asthma]. Pneumonol Alergol Pol (2006) 0.75
[Clinical effects of surgical treatment of obstructive sleep apnea syndrome]. Pol Arch Med Wewn (2002) 0.75
[Use of mycolic acids analysis in diagnosis of tuberculosis and mycobacteriosis--three-year experience]. Pneumonol Alergol Pol (2002) 0.75
[The comparison between two methods for typing of nontuberculous mycobacteria: high pressure liquid chromatography and molecular assay GenoType Mycobacterium CM/AS]. Pneumonol Alergol Pol (2010) 0.75
[Effect of nasal obstruction on subjective assessment of sleep quality by the patients with obstructive sleep apnea]. Pol Merkur Lekarski (2005) 0.75
Development of an electronic manometer for intrapleural pressure monitoring. Respiration (2011) 0.75
[Correlation between bronchoscopically visible aspects and histopathologic results in patients with suspected lung cancer]. Pol Arch Med Wewn (2002) 0.75
[The use of induced sputum examination in respiratory system diseases]. Pol Merkur Lekarski (2011) 0.75
Left brachiocephalic vein stenosis and infectious aortitis: two unusual causes of Ortner's syndrome. Pneumonol Alergol Pol (2015) 0.75
PDE4 inhibitors have no effect on eotaxin expression in human primary bronchial epithelial cells. Acta Biochim Pol (2012) 0.75
[Reproducibility of exhaled nitric oxide (FENO) measurements in healthy subjects]. Pneumonol Alergol Pol (2004) 0.75
[Angiotensin-converting enzyme gene polymorphism in patients with obstructive sleep apnea]. Pol Arch Med Wewn (2004) 0.75
[Influence of nasal continuous positive airway pressure on response to exercise in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2006) 0.75
[Endocrine disorders related to obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2007) 0.75
[Coagulation parameters associated with inhaled glucocorticosteroid therapy in stable asthma]. Pol Merkur Lekarski (2005) 0.75
[Radial segmentation of lymphocytes in peripheral blood of patients with non-small cell lung cancer ]. Wiad Lek (2002) 0.75
Treatment with continuous positive airway pressure and diurnal and nocturnal serum melatonin concentration in patients with obstructive sleep apnea. Pol Arch Intern Med (2017) 0.75